Ryo Hatano

1.2k total citations
45 papers, 822 citations indexed

About

Ryo Hatano is a scholar working on Oncology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ryo Hatano has authored 45 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 14 papers in Immunology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ryo Hatano's work include Peptidase Inhibition and Analysis (23 papers), Neuropeptides and Animal Physiology (10 papers) and Protease and Inhibitor Mechanisms (7 papers). Ryo Hatano is often cited by papers focused on Peptidase Inhibition and Analysis (23 papers), Neuropeptides and Animal Physiology (10 papers) and Protease and Inhibitor Mechanisms (7 papers). Ryo Hatano collaborates with scholars based in Japan, United States and Hong Kong. Ryo Hatano's co-authors include Chikao Morimoto, Kei Ohnuma, Nam H. Dang, Satoshi Iwata, Taketo Yamada, Eriko Komiya, Haruna Otsuka, Thomas M. Aune, Takumi Itoh and Toshihiro Okamoto and has published in prestigious journals such as Nature Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

Ryo Hatano

42 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Hatano Japan 17 320 300 165 124 122 45 822
David W. LaFleur United States 17 355 1.1× 531 1.8× 402 2.4× 96 0.8× 19 0.2× 22 1.2k
Elisabeth H. Vollmann United States 8 146 0.5× 742 2.5× 240 1.5× 33 0.3× 92 0.8× 9 1.1k
María Ángeles García-López Spain 13 233 0.7× 546 1.8× 254 1.5× 21 0.2× 105 0.9× 20 1.0k
Rosa Barreira da Silva United States 12 456 1.4× 722 2.4× 521 3.2× 35 0.3× 62 0.5× 16 1.3k
Kathy Barrett United Kingdom 11 252 0.8× 435 1.4× 355 2.2× 35 0.3× 78 0.6× 20 1.1k
Amanda Proudfoot Switzerland 12 350 1.1× 440 1.5× 277 1.7× 30 0.2× 54 0.4× 14 1.0k
Daniela Giunciuglio Italy 15 261 0.8× 226 0.8× 500 3.0× 32 0.3× 32 0.3× 18 1.0k
Marynette Rihanek United States 12 262 0.8× 459 1.5× 403 2.4× 19 0.2× 103 0.8× 16 1.0k
Ashley J. Chui United States 10 261 0.8× 405 1.4× 946 5.7× 69 0.6× 31 0.3× 12 1.1k
Sabine Zahn Germany 14 148 0.5× 753 2.5× 422 2.6× 85 0.7× 18 0.1× 18 1.2k

Countries citing papers authored by Ryo Hatano

Since Specialization
Citations

This map shows the geographic impact of Ryo Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Hatano more than expected).

Fields of papers citing papers by Ryo Hatano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Hatano. The network helps show where Ryo Hatano may publish in the future.

Co-authorship network of co-authors of Ryo Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Hatano. A scholar is included among the top collaborators of Ryo Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Hatano. Ryo Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumura, Takeshi, Takafumi Senokuchi, Hiroyuki Motoshima, et al.. (2025). Hematopoietic dipeptidyl peptidase-4 deficiency promotes M2 macrophage polarization and attenuates atherosclerosis. Biochemical and Biophysical Research Communications. 794. 153037–153037.
2.
Kawasaki, Takeshi, Koichiro Tatsumi, Tomohisa Okaya, et al.. (2024). Transcriptome Analysis of Fibroblasts in Hypoxia-Induced Vascular Remodeling: Functional Roles of CD26/DPP4. International Journal of Molecular Sciences. 25(23). 12599–12599. 1 indexed citations
3.
Hatano, Ryo, Hayato Nakamura, Ayako Yamamoto, et al.. (2024). An abnormal increase in CD26(−)CD28(−) cytotoxic effector CD4 and CD8 T cell populations in patients with systemic lupus erythematosus. International Immunology. 37(3). 153–172.
4.
Sato, Shunichi, Takeshi Kawasaki, Ryo Hatano, et al.. (2024). Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(5). L562–L573. 3 indexed citations
5.
Kawasaki, Takeshi, Shunichi Sato, Koichiro Tatsumi, et al.. (2024). Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease. International Journal of Molecular Sciences. 25(2). 748–748. 6 indexed citations
6.
Kawasaki, Takeshi, Yoshitoshi Kasuya, Ryo Hatano, et al.. (2023). Functional roles of CD26/DPP4 in bleomycin‐induced pulmonary fibrosis. Physiological Reports. 11(6). e15645–e15645. 6 indexed citations
7.
Kobayashi, Eiji, Yusuke Kamihara, Akinori Wada, et al.. (2023). Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells. 12(16). 2059–2059. 5 indexed citations
9.
Hatano, Ryo, Takumi Itoh, Haruna Otsuka, et al.. (2022). Humanized anti-IL-26 monoclonal antibody as a novel targeted therapy for chronic graft-versus-host disease. American Journal of Transplantation. 22(12). 2804–2820. 1 indexed citations
10.
Hatano, Ryo, Taketo Yamada, Haruna Otsuka, et al.. (2019). Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens. PLoS ONE. 14(6). e0218330–e0218330. 4 indexed citations
11.
Komiya, Eriko, Ryo Hatano, Haruna Otsuka, et al.. (2017). A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus. Journal of Dermatological Science. 86(3). 212–221. 8 indexed citations
12.
Abe, Masaaki, Shuji Matsuoka, Kazunori Kajino, et al.. (2016). Establishment of anti-mesothelioma monoclonal antibodies. BMC Research Notes. 9(1). 324–324. 1 indexed citations
13.
Iwata, Satoshi, Naoki Oyaizu, Osamu Hosono, et al.. (2015). The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine model. Biochemical and Biophysical Research Communications. 460(4). 1069–1075. 7 indexed citations
14.
Kwan, Jason C., Ranjala Ratnayake, Ryo Hatano, et al.. (2014). Grassypeptolides as Natural Inhibitors of Dipeptidyl Peptidase 8 and T‐Cell Activation. ChemBioChem. 15(6). 799–804. 20 indexed citations
15.
Yamamoto, Junpei, Kei Ohnuma, Ryo Hatano, et al.. (2014). Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma. British Journal of Cancer. 110(9). 2232–2245. 15 indexed citations
16.
Okamoto, Toshihiro, Satoshi Iwata, Hiroto Yamazaki, et al.. (2014). CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells. PLoS ONE. 9(1). e86671–e86671. 29 indexed citations
17.
Hatano, Ryo, et al.. (2013). Antigen presentation by small intestinal epithelial cells uniquely enhances IFN-γ secretion from CD4+ intestinal intraepithelial lymphocytes. Biochemical and Biophysical Research Communications. 435(4). 592–596. 9 indexed citations
18.
Ohnuma, Kei, et al.. (2013). Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors. Diabetes Research and Clinical Practice. 102(1). e8–e12. 26 indexed citations
19.
Kawaguchi, Tatsuya, et al.. (2011). Fibronectin promotes proplatelet formation in the human megakaryocytic cell line UT‐7/TPO. Cell Biology International. 36(1). 39–45. 10 indexed citations
20.
Ohnuma, Kei, et al.. (2010). Inhibition of dipeptidyl peptidase 4 regulates microvascular endothelial growth induced by inflammatory cytokines. Biochemical and Biophysical Research Communications. 401(1). 7–12. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026